Selected as a recipient company for the 13th term of the Small and Medium Enterprise Infrastructure Development Organization's acceleration program "FASTAR".
Our company has been selected as a recipient of support for the 13th term of "FASTAR," an acceleration program run by the Organization for Small & Medium Enterprises and Regional Innovation, JAPAN. Using this program as a springboard, we will strongly promote the development of angiogenesis therapy using ICS for severe lower limb ischemia. https://www.smrj.go.jp/press/2025/fc3pqu0000004c79-att/20250930_press01.pdf
Sep 30, 2025
Selected for the MEDISO Acceleration Program Direct Flight "Philadelphia Program"
We have been selected for the Direct Flight "Philadelphia Program," a program run by MEDISO (a medical venture total support project commissioned by the Ministry of Health, Labour and Welfare) to promote the overseas expansion of medical startups . Using this program as a springboard, we will accelerate the overseas expansion of angiogenesis therapy using ICS for critical lower limb ischemia. https://mediso.mhlw.go.jp/topics_page/20250903-02/
Sep 3, 2025